Microvascular decompression (MVD) is a potential treatment option for individuals with classical or idiopathic trigeminal neuralgia (TN) and neurovascular contact (NVC).
Why this matters
TN is associated with severe, debilitating pain that impacts individuals’ physical, mental, and social wellbeing.
Current pharmacological treatments for TN are associated with limiting side effects.
Findings from this study can help to determine if MVD is a suitable treatment for these individuals.